Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether EP-4 receptor antagonist can prevent the headache expected during a Prostaglandin E2 infusion.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Danish Headache Center
NCT04715685 · Headache, Headache Disorders, and more
NCT06617832 · Migraine with Aura, Migraine Without Aura, and more
NCT05232942 · Migraine, Headache, Migraine
NCT07373275 · Headache, Migraine
NCT06083571 · Headache, Migraine
Danish Headache Center
Glostrup Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions